Definitive Contract HHSD200201562835C
Award Date 7/1/15
Potential Completion Date 6/30/16
Potential Value $62M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27709, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $1,085,922,457.04 firm fixed price contract to Glaxosmithkline, LLC for the provision of vaccines for children. The contract, which did not have a set-aside designation, has a performance period ending on March 31, 2018. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, provides a range of vaccines, antivirals, and other pharmaceutical products to federal agencies including the...
- This is a $50,556,695.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The contract, titled "2016 VFA - GSK", is for a firm fixed price and has an ultimate completion date of June 30, 2017. It is not a set-aside contract. Glaxosmithkline has provided a range of pharmaceutical goods and...
- This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to GlaxoSmithKline, LLC on December 23, 2016 for the 2017 adult flu season. The firm fixed price contract has a ceiling value of $12,408,000.00 and a performance period ending February 28, 2018. The contract does not have a set-aside designation. GlaxoSmithKline, a pharmaceutical company, has provided a range of products to U.S. government agencies through federal contracts, including influenza...
- This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to GlaxoSmithKline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The contract has a total ceiling value of $213,831.06 and was awarded on a firm fixed price basis with no set-aside designation. It is a delivery order under GlaxoSmithKline's existing General Services Administration Federal Supply Schedule...
- This is a $69,857,670.45 firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, doing business as Glaxosmithkline, for 2016 pandemic influenza preparedness efforts. The contract has a completion date of February 28, 2017 and was awarded on December 18, 2015. There was no set-aside designation used. Glaxosmithkline is a pharmaceutical company that provides vaccines, antiviral medications, and other products to various federal agencies,...
- The U.S. government's Bureau of Administration, a civilian agency, awarded a firm fixed-price delivery order contract to GlaxoSmithKline, LLC for the provision of 2025-2026 influenza vaccines. The contract has a ceiling value of $667,575.00 and an ultimate completion date of October 9, 2025. This award is not set aside for any specific business type. GlaxoSmithKline, a foreign-owned, for-profit pharmaceutical company, has been a critical supplier of vaccines, antivirals, and medical...
- This is a federal contract award by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to GlaxoSmithKline, LLC, a pharmaceutical company, for the delivery of influenza vaccines. The contract is a Delivery Order issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with a Firm Fixed Price pricing type and a potential value of $1,319,230.00. There was no set-aside designation used for this award. GlaxoSmithKline has provided a...
- The U.S. government awarded a $171,258 firm fixed price delivery order contract to Glaxosmithkline, LLC for the provision of vaccines. The contract was awarded by the Office of the Assistant Secretary for Administration, a civilian federal agency, and was issued under Glaxosmithkline's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The contract has a period of performance ending on January 31, 2020 and does not have a set-aside designation. Glaxosmithkline has provided a...
- The Department of Health and Human Services awarded a $121,391.84 firm fixed-price delivery order to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of vaccines. This award is part of a larger General Services Administration Federal Supply Schedule 61 contract for pharmaceuticals and drugs. The contract does not have a set-aside designation and the place of performance is Glaxosmithkline's facility in Research Triangle Park, North Carolina. Glaxosmithkline is a major supplier...
- This is a modification to a $49,999,745.68 firm fixed price delivery order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Glaxosmithkline, LLC. The contract is for the provision of pharmaceutical products including vaccines, antiviral medications, and vaccine adjuvants to support various U.S. government agencies. The contract has no set-aside designation. Glaxosmithkline has a history of providing a range of pharmaceutical products...